Scientists Make a Major Breakthrough in Prostate Cancer Research

635622690850950671omega 3 hookweb.jpg

18 Mar 2015 --- Washington State University researchers have found a mechanism by which omega-3 fatty acids inhibit the growth and spread of prostate cancer cells. The findings, which are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, point the way to more effective anti-cancer drugs.

Scientists have long known that omega 3s reduce inflammation and have anti-diabetic effects, and some recently discovered how this happens. 

"But we're the first to show that they work this way in cancer," said Kathryn Meier, a professor of pharmacy at WSU Spokane. "The attention has mostly been on inflammation and diabetes but there has always been an interest in cancer, and we were the first to show this mechanism in any cancer cell at all. And we're using prostate cancer, which is the most controversial subject in omega 3s." 

A 2013 study in the Journal of the National Cancer Institute found that men with higher levels of omega-3 fatty acids in their blood had a greater risk of developing prostate cancer. It was not clear if the fatty acids came from food--certain fish, seeds and nuts are high in omega 3s--or supplements like fish oil. 

Working with prostate cell cultures, Meier and two students, Ze Liu and Mandi Hopkins, found the fatty acids bind to a receptor called FFA4, for "free fatty acid receptor 4." Rather than stimulating cancer cells, the receptor acts as a signal to inhibit growth factors, suppressing proliferation of the cancer cells. 

"This kind of knowledge could lead us to better treat or prevent cancer because now we know how it works," Meier said. The study also found that a drug mimicking the action of omega 3s can work as well or better than fatty acids in suppressing the cancer cells. 

The study appears in the Journal of Pharmacology and Experimental Therapeutics. 

Meier said it is still unclear if the effect can be obtained by taking dietary supplements like fish oil. Some people don't tolerate fish oil very well, she said. Moreover, the effect of fish oil could fade as it is digested, while data from this study suggest that an omega-3 drug needs to be in a cancer cell all the time to have an effect. 

"It's very difficult in dietary studies to tell how much to take or what form to take," Meier said. "Should you be eating fish? Should you be taking pills? But now we have a potential drug. Once you have a drug you can test very precisely whether it works or not in a certain disease and you would know exactly how much to give people." 

Related Articles

Business News

Dynamic OTC marketplace: Albertsons and Rite Aid merge, Amazon enters the fray

21 Feb 2018 --- Albertsons Companies, one of the US’ largest grocery retailers, and leading drugstore chain Rite Aid Corporation have announced a definitive merger agreement, creating a retail behemoth with US$83 billion in annual revenue. The move is thought to give the integrated company more weight to compete with bigger chains in an industry anxious about the reported entry of Amazon.com.

Nutrition & Health News

Chronic heavy drinking major risk factor for dementia: The Lancet

21 Feb 2018 --- Excessive alcohol use is a major risk factor for onset of all types of dementia, especially early-onset dementia, according to a French nationwide observational study, published in The Lancet Public Health journal. Previous research has shown mixed results regarding the effect of alcohol on cognitive health, with some studies showing a possible benefit of light to moderate drinking, while others have found detrimental effects of heavy drinking on dementia risk.

Business News

Lonza to expand Florida encapsulation capabilities amid product development acceleration

21 Feb 2018 --- Swiss multinational, chemicals and biotechnology company, the Lonza Group is planning to expand its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company will install a new Harro Hӧfliger Modu-C MS encapsulation unit (Harro unit) at its integrated product development and manufacturing facility in Tampa, Florida, to strengthen production and bring its products to market faster. 

Nutrition & Health News

Gluten-free bakery: Growing demand for products with extra nutritional benefits, DuPont survey reveals

20 Feb 2018 --- European consumers are looking for gluten-free bakery products that match regular products in terms of taste and texture, but also offer additional health benefits such as high fiber, a DuPont Nutrition & Health consumer survey has revealed. The survey results show untapped potential for bakers to develop more and better-quality products with extra nutritional benefits, and the company notes that customized ingredient solutions are the way to tapping into this potential.

Nutrition & Health News

ExcelVite palm tocotrienol complex eases severe pain, diabetic patient study reveals

20 Feb 2018 --- Researchers at the University Science of Malaysia have found that daily doses of EVNol SupraBio – a bio-enhanced full spectrum palm tocotrienol complex – can help to relieve severe pain (lancinating pain) in diabetic neuropathy patients. Focusing on diabetic neuropathy patients (DPN), this Vitamin E Neuroprotection Study (VENUS) was a randomized, double-blind clinical trial carried out to discover how to better manage the challenging issue of painful neuropathy. It is the largest tocotrienol human clinical study of its kind. 

More Articles
URL : http://www.nutritioninsight.com:80/news/scientists-make-a-major-breakthrough-in-prostate-cancer-research.html